May 21, 2026 – State of Connecticut Regulatory Alert
The option to upload reports is now available on the Connecticut portal. All registered manufacturers should have received an email directly from the state with instructions on how to complete these requirements.
The following are also required apart from the transparency report:
- A registration fee of $150 will be due as part of the application/registration renewal fee
- An updated roster of representatives and products promoted
- Note: In Connecticut a “Pharmaceutical representative” means any person, including, but not limited to, a sales representative, who markets, promotes or provides information regarding a legend drug for human use to a prescribing practitioner and is employed or compensated by a pharmaceutical manufacturer (https://www.cga.ct.gov/current/pub/chap_417.htm#sec_21a-70h)
Pharmaceutical Manufactures must renew their registration by June 30, 2026, Reports are due to the state by July 1, 2026.
If anyone requires further assistance, please feel free to contact me at Katherine.Pereira@Qpharmacorp.com and I can walk through the portal with you, or you can reach out directly to CT through both of these emails: DCP.DrugManufacturers@ct.gov and DCP.Online@ct.gov
